Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans

被引:36
作者
Carpentier, A
Patterson, BW
Leung, N
Lewis, GF
机构
[1] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
[3] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA
关键词
D O I
10.2337/diabetes.51.6.1867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One important mechanism whereby obesity-associated insulin resistance leads to VLDL overproduction is thought to be by the increased flux of free fatty acids (FFAs) from extrahepatic tissues to liver, which arises as a direct consequence of impaired insulin action in adipose tissue and skeletal muscle. The aim of the present study was to address whether direct measures of peripheral tissue insulin sensitivity with regard to FFAs and glucose in the fasting state are good predictors of postabsorptive VLDL triglyceride secretion rate (VLDL-TG ASR) in humans, independent of obesity. Eighteen healthy control subjects, after an overnight fast, underwent three studies 3 weeks apart, in random order. Study 1: VLDL-TG levels, fractional clearance rate (per h), and VLDL-TG ASR were determined after an intravenous bolus of [1,1,2,3,3-H-2(5)]glycerol. Study 2: Insulin sensitivity (SI), acute insulin response (AIR), and acute C-peptide response to glucose were assessed by frequently sampled intravenous glucose tolerance test using the minimal model approach. Study 3: Insulin-mediated suppression of plasma FFAs (k) and insulin clearance were assessed in response to a low-dose stepwise intravenous insulin infusion. BMI (R-2 = 0.54), AIR, and fasting insulin levels were positively and S, negatively correlated with VLDL-TG ASR, but there was no significant association with plasma FFAs or k. Only BMI remained significantly associated with VLDL-TG ASR in multivariate analysis. The best multivariate model for VLDL-TG ASR (R-2 = 0.61, P = 0.0008) included BMI (P = 0.0008) and S-I (P = 0.12, inversely correlated). VLDL-TG secretion is predicted by BMI, independently of direct measures of insulin sensitivity. The sensitivity to insulin's acute suppressive effect on plasma FFA levels during fasting is not an important determinant of postabsorptive VLDL-TG secretion in humans.
引用
收藏
页码:1867 / 1875
页数:9
相关论文
共 58 条
  • [1] Aarsland A, 1998, J LIPID RES, V39, P1280
  • [2] Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance
    Abbasi, F
    McLaughlin, T
    Lamendola, C
    Reaven, GM
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (02): : 151 - 154
  • [3] Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity
    Albu, JB
    Curi, M
    Shur, M
    Murphy, L
    Matthews, DE
    Pi-Sunyer, FX
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03): : E551 - E560
  • [4] Baldeweg SE, 2000, EUR J CLIN INVEST, V30, P45
  • [5] ASSESSMENT OF INSULIN SENSITIVITY INVIVO
    BERGMAN, RN
    FINEGOOD, DT
    ADER, M
    [J]. ENDOCRINE REVIEWS, 1985, 6 (01) : 45 - 86
  • [6] Prevalence of insulin resistance in metabolic disorders - The Bruneck Study
    Bonora, E
    Kiechl, S
    Willeit, J
    Oberhollenzer, F
    Egger, G
    Targher, G
    Alberiche, M
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES, 1998, 47 (10) : 1643 - 1649
  • [7] Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men
    Boquist, S
    Hamsten, A
    Karpe, E
    Ruotolo, G
    [J]. DIABETOLOGIA, 2000, 43 (02) : 185 - 193
  • [8] Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
    Byrne, MM
    Sturis, J
    Menzel, S
    Yamagata, K
    Fajans, SS
    Dronsfield, MJ
    Bain, SC
    Hattersley, AT
    Velho, G
    Froguel, P
    Bell, GI
    Polonsky, KS
    [J]. DIABETES, 1996, 45 (11) : 1503 - 1510
  • [9] The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism
    Carpentier, A
    Patterson, BW
    Uffelman, KD
    Giacca, A
    Vranic, M
    Cattral, MS
    Lewis, GF
    [J]. DIABETES, 2001, 50 (06) : 1402 - 1413
  • [10] COPPACK SW, 1994, J LIPID RES, V35, P177